Transient blockade of the CD11d/CD18 integrin reduces secondary damage after spinal cord injury, improving sensory, autonomic, and motor function.

Authors:
Denis Gris
Denis Gris
University of Western Ontario
Canada
Daniel R Marsh
Daniel R Marsh
Dalhousie University
Canada
Mark A Oatway
Mark A Oatway
Robarts Research Institute
London | Canada
Yuhua Chen
Yuhua Chen
Robarts Research Institute
Canada
Eilis F Hamilton
Eilis F Hamilton
University of Western Ontario
Canada
Gregory A Dekaban
Gregory A Dekaban
Robarts Research Institute
Canada
Lynne C Weaver
Lynne C Weaver
Robarts Research Institute
Canada

J Neurosci 2004 Apr;24(16):4043-51

Spinal Cord Injury Team, BioTherapeutics Research Group, Robarts Research Institute, University of Western Ontario, London, Ontario N6A 5K8, Canada.

The early inflammatory response to spinal cord injury (SCI) causes significant secondary damage. Strategies that nonselectively suppress inflammation have not improved outcomes after SCI, perhaps because inflammation has both adverse and beneficial effects after SCI. We have shown that the selective, time-limited action of a monoclonal antibody (mAb) to the CD11d subunit of the CD11d/CD18 integrin, delivered intravenously during the first 48 hr after SCI in rats, markedly decreases the infiltration of neutrophils and delays the entry of hematogenous monocyte-macrophages into the injured cord. We hypothesized that this targeted strategy would lead to neuroprotection and improved neurological outcomes. In this study the development of chronic pain was detected in rats by assessing mechanical allodynia on the trunk and hindpaws 2 weeks to 3 months after a clinically relevant clip-compression SCI at the twelfth thoracic segment. The anti-CD11d mAb treatment reduced this pain by half. Motor performance also improved as rats were able to plantar-place their hindpaws and use them for weight support instead of sweeping movements only. Improved cardiovascular outcome was shown after SCI at the fourth thoracic segment by significant decreases in autonomic dysreflexia. Locomotor performance was also improved. These functional changes correlated with significantly greater amounts and increased organization of myelin and neurofilament near the lesion. The improved neurological recovery after the specific reduction of early inflammation after SCI demonstrates that this selective strategy increases tissue at the injury site and improves its functional capacity. This early neuroprotective treatment would be an ideal foundation for building later cell-based therapies.

Download full-text PDF

Source
http://dx.doi.org/10.1523/JNEUROSCI.5343-03.2004DOI Listing

Still can't find the full text of the article?

Sign up to send a request to the authors directly.
April 2004
26 Reads

Publication Analysis

Top Keywords

spinal cord
8
cord injury
8
performance improved
8
thoracic segment
8
secondary damage
8
improved neurological
8
cd11d/cd18 integrin
8
sci
7
improved
6
detected rats
4
rats assessing
4
pain detected
4
neurological recovery
4
development chronic
4
chronic pain
4
study development
4
recovery specific
4
mechanical allodynia
4
neurofilament lesion
4
hindpaws weeks
4

Similar Publications

Aberrant Sialylation in Cancer Pathology and Metastasis, a Putative Drug Target Candidate.

Anticancer Agents Med Chem 2018 09 10. Epub 2018 Sep 10.

Divisions of Biochemistry & Chemistry, City University of New York School of Medicine, 160 Convent Avenue, New York, NY10031. United States.

Backgrounds: Neoplasm metastasis is a multi-step and multi-level pathological feature causing 90% of cancer mortality due to a shortage of effective drugs and clinical therapeutics. To change this scenario, new drug targets and developments are required.

Method: Aberrant tumor sialylation as a putative drug target candidate has been evolving over the past half century. Read More

View Article
September 2018
46 Reads
2.47 Impact Factor

Antimicrobial and antioxidant activities of triterpenoid and phenolic derivatives from two Cameroonian Melastomataceae plants: Dissotis senegambiensis and Amphiblemma monticola.

BMC Complement Altern Med 2018 May 16;18(1):159. Epub 2018 May 16.

Laboratory of Microbiology and Antimicrobial substances, Department of Biochemistry, Faculty of Science, University of Dschang, P.O. Box 67, Dschang, Cameroon.

Background: Antimicrobial resistance is a serious threat against humankind and the search for new therapeutics is needed. This study aims to investigate the antimicrobial and antioxidant activities of ethanol extracts and compounds isolated from Dissotis senegambiensis and Amphiblemma monticola, two Cameroonian Melastomataceae species traditionally used for the treatment of fever, malaria and infectious diseases.

Methods: The plant extracts were prepared by maceration in ethanol. Read More

View Article
May 2018
13 Reads
2.02 Impact Factor

A complete categorization of multiscale models of infectious disease systems.

Authors:
Winston Garira

J Biol Dyn 2017 Dec;11(1):378-435

a Modelling Health and Environmental Linkages Research Group (MHELRG), Department of Mathematics and Applied Mathematics , University of Venda , Thohoyandou, South Africa.

Modelling of infectious disease systems has entered a new era in which disease modellers are increasingly turning to multiscale modelling to extend traditional modelling frameworks into new application areas and to achieve higher levels of detail and accuracy in characterizing infectious disease systems. In this paper we present a categorization framework for categorizing multiscale models of infectious disease systems. The categorization framework consists of five integration frameworks and five criteria. Read More

View Article
December 2017
16 Reads

Systematic assessment of the performance of illumina's MiSeq FGx™ forensic genomics system.

Electrophoresis 2017 03 30;38(6):846-854. Epub 2017 Jan 30.

Office of Chief Medical Examiner, Department of Forensic Biology, New York, NY, USA.

This study assesses the performance of Illumina's MiSeq FGx System for forensic genomics by systematically analyzing single source samples, evaluating concordance, sensitivity and repeatability, as well as describing the quality of the reported outcomes. DNA from 16 individuals (9 males/7 females) in nine separate runs showed consistent STR profiles at DNA input ≥400 pg, and two full profiles were obtained with 50 pg DNA input. However, this study revealed that the outcome of a single sample does not merely depend on its DNA input but is also influenced by the total amount of DNA loaded onto the flow cell from all samples. Read More

View Article
March 2017
10 Reads
2 PubMed Central Citations(source)
3.03 Impact Factor

ATM kinase is a master switch for the Delta Np63 alpha phosphorylation/degradation in human head and neck squamous cell carcinoma cells upon DNA damage.

Cell Cycle 2008 Sep 15;7(18):2846-55. Epub 2008 Sep 15.

Department of Dermatology, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21231, USA.

We previously found that the pro-apoptotic DNA damaging agent, cisplatin, mediated the proteasome-dependent degradation of Delta Np63 alpha associated with its increased phosphorylated status. Since Delta Np63 alpha usually plays an opposite role to p53 and TAp63 in human cancers, we tested the notion that phosphorylation events induced by DNA damage would affect the protein degradation of Delta Np63 alpha in HNSCC cells upon cisplatin exposure. We found that Delta Np63 alpha is phosphorylated in the time-dependent fashion at the following positions: S385, T397 and S466, which were surrounded by recognition motifs for ATM, CDK2 and p70s6K kinases, respectively. Read More

View Article
September 2008
26 Reads
23 PubMed Central Citations(source)